Ben Ayres

We know that TURBT procedure is critical in the care of patients with non-muscle invasive bladder cancer. With data that shows that CIS was missed by TURBT in more than 45% of radical cystectomy cases and 86% of residual tumors have been found at the original resection site, it's clear that enhanced visualization could be a significant benefit during TURBT's.

We know that TURBT procedure is critical in the care of patients with non-muscle invasive bladder cancer. With data that shows that CIS was missed by TURBT in more than 45% of radical cystectomy cases and 86% of residual tumors have been found at the original resection site, it's clear that enhanced visualization could be a significant benefit during TURBT's.

We know that TURBT procedure is critical in the care of patients with non-muscle invasive bladder cancer. With data that shows that CIS was missed by TURBT in more than 45% of radical cystectomy cases and 86% of residual tumors have been found at the original resection site, it's clear that enhanced visualization could be a significant benefit during TURBT's.

Further, with only 23% of patients coming back for re-resection, it's all the more important to do a complete TURBT right from the start.

Further, with only 23% of patients coming back for re-resection, it's all the more important to do a complete TURBT right from the start.

Further, with only 23% of patients coming back for re-resection, it's all the more important to do a complete TURBT right from the start.

Hello and welcome to this podcast on the unmet psychological needs in penile cancer. I'm Ben Ayres. I'm a consultant urological surgeon working in London in the United Kingdom and I specialize in managing patients with penile cancer. We do have a centralized service in the UK and therefore we end up at our center gaining a lot of experience in managing these patients.

Hello and welcome to this podcast on the unmet psychological needs in penile cancer. I'm Ben Ayres. I'm a consultant urological surgeon working in London in the United Kingdom and I specialize in managing patients with penile cancer. We do have a centralized service in the UK and therefore we end up at our center gaining a lot of experience in managing these patients.

Hello and welcome to this podcast on the unmet psychological needs in penile cancer. I'm Ben Ayres. I'm a consultant urological surgeon working in London in the United Kingdom and I specialize in managing patients with penile cancer. We do have a centralized service in the UK and therefore we end up at our center gaining a lot of experience in managing these patients.

I'm delighted to be joined this evening by my two colleagues and I'll let them introduce themselves. So Rick, please say hello to the audience.

I'm delighted to be joined this evening by my two colleagues and I'll let them introduce themselves. So Rick, please say hello to the audience.

I'm delighted to be joined this evening by my two colleagues and I'll let them introduce themselves. So Rick, please say hello to the audience.

Thank you, Rick. And we're also delighted to be joined this evening by Rob Corns. Rob, please introduce yourself.

Thank you, Rick. And we're also delighted to be joined this evening by Rob Corns. Rob, please introduce yourself.

Thank you, Rick. And we're also delighted to be joined this evening by Rob Corns. Rob, please introduce yourself.

Well, thank you both for joining us this evening. And as I say, hopefully we're going to have a good and useful conversation about how we can really increase the awareness and advocacy around this very rare cancer and perhaps what clinicians can do to try and bring a more holistic approach to managing these patients' needs.

Well, thank you both for joining us this evening. And as I say, hopefully we're going to have a good and useful conversation about how we can really increase the awareness and advocacy around this very rare cancer and perhaps what clinicians can do to try and bring a more holistic approach to managing these patients' needs.

Well, thank you both for joining us this evening. And as I say, hopefully we're going to have a good and useful conversation about how we can really increase the awareness and advocacy around this very rare cancer and perhaps what clinicians can do to try and bring a more holistic approach to managing these patients' needs.

Because as I think we're going to discuss, a lot of their psychosocial needs, unfortunately, are often left behind. We're very grateful this evening that we're able to do this podcast and we've been given this opportunity by Backtable and also by the Global Society of Rare Genital Urinary Tumors, a group that is really passionate about.

Because as I think we're going to discuss, a lot of their psychosocial needs, unfortunately, are often left behind. We're very grateful this evening that we're able to do this podcast and we've been given this opportunity by Backtable and also by the Global Society of Rare Genital Urinary Tumors, a group that is really passionate about.